XML 59 R40.htm IDEA: XBRL DOCUMENT v3.21.1
BUSINESS COMBINATIONS - Narrative (Details)
$ in Thousands, £ in Millions
3 Months Ended 12 Months Ended
Mar. 30, 2021
USD ($)
Mar. 30, 2021
GBP (£)
Mar. 29, 2021
USD ($)
Mar. 03, 2021
USD ($)
Dec. 31, 2020
USD ($)
Aug. 06, 2020
USD ($)
Jan. 03, 2020
USD ($)
Mar. 27, 2021
USD ($)
Mar. 28, 2020
USD ($)
Dec. 26, 2020
USD ($)
Business Acquisition [Line Items]                    
Goodwill               $ 1,890,630   $ 1,809,168
Retrogenix Limited                    
Business Acquisition [Line Items]                    
Integration related costs and transaction costs               800    
Retrogenix Limited | Subsequent Event                    
Business Acquisition [Line Items]                    
Purchase price $ 48,000 £ 35                
Consideration contingent upon future performance $ 7,000 £ 5                
Cognate BioServices, Inc.                    
Business Acquisition [Line Items]                    
Integration related costs and transaction costs               7,200    
Cognate BioServices, Inc. | Subsequent Event                    
Business Acquisition [Line Items]                    
Purchase price     $ 875,000              
Distributed Bio, Inc.                    
Business Acquisition [Line Items]                    
Purchase price         $ 97,000          
Consideration contingent upon future performance         21,000          
Contingent consideration liability         14,000          
Purchase price allocation         97,030          
Cash acquired         800          
Integration related costs and transaction costs               700    
Cash portion of consideration transferred         80,800          
Payments to settle promissory note         3,000          
Goodwill         $ 71,585          
Weighted-average amortization life         7 years          
Definite-lived intangible assets         $ 24,540          
Property, plant and equipment         $ 2,382          
Cellero, LLC                    
Business Acquisition [Line Items]                    
Purchase price           $ 37,400        
Purchase price allocation           36,850        
Cash acquired           500        
Integration related costs and transaction costs               400    
Goodwill, amount expected to be deductible for tax purposes           10,800        
Goodwill           $ 19,457        
Weighted-average amortization life           12 years        
Definite-lived intangible assets           $ 16,230        
Property, plant and equipment           $ 1,648        
HemaCare Corporation                    
Business Acquisition [Line Items]                    
Purchase price             $ 379,800      
Purchase price allocation             376,721      
Cash acquired             3,100      
Integration related costs and transaction costs               $ 100 $ 5,700  
Goodwill             $ 210,196      
Weighted-average amortization life             18 years      
Definite-lived intangible assets             $ 183,540      
Property, plant and equipment             $ 10,033      
Other Acquisitions                    
Business Acquisition [Line Items]                    
Purchase price       $ 35,600            
Contingent consideration liability       15,900            
Cash portion of consideration transferred       19,700           $ 5,500
Goodwill       17,300            
Definite-lived intangible assets       15,200            
Property, plant and equipment       $ 3,000            
Other Acquisitions | Supplier relationships                    
Business Acquisition [Line Items]                    
Weighted-average amortization life       4 years            
Other Acquisitions | Maximum                    
Business Acquisition [Line Items]                    
Contingent consideration liability       $ 17,500            
Depreciation and Amortization Expense | HemaCare Corporation                    
Business Acquisition [Line Items]                    
Adjustments related to prior period                 $ 200